Sanofi’s Wayrilz recommended for EU approval by the CHMP to treat immune thrombocytopenia
Press Release: Sanofi’s Wayrilz recommended for EU approval by the CHMP to treat immune thrombocytopenia
Seeking Alpha / 1 hour from now 1 Views
Seeking Alpha / 1 hour from now 1 Views
Sanofi’s Wayrilz recommended for EU approval by the CHMP to treat immune thrombocytopenia
Comments